Renal
-
Kolling NEWS – May feature
Posted on:
Check out our Kolling Institute newsletter – profiling the latest impactful research across the Kolling. It’s an insight into the talented investigators behind the scenes, and their exciting progress to improve the care we all receive. Our researchers are driving investigations into new cancer therapies, diabetes, and painful, musculoskeletal conditions, and crucially, developing new life-changing
Category:
-
2026 Beryl and Jack Jacobs Travel Awards announced
Posted on:
A collection of five early-to-mid career researchers will share close to $40,000 in funding through the Skipper Jacobs Charitable Trust. The Skipper family has generously supported emerging research talent at the Kolling Institute for many years, providing invaluable travel and career opportunities. This year’s group has welcomed the chance to travel internationally, meet with research
Category:
-
New study tests how stress and big meals can trigger a heart attack
Posted on:
A heavy Christmas lunch, an argument or even smoke from a bushfire may seem harmless, but for people at risk of heart disease, they could be deadly. A new study is investigating how emotional stress, pollution, chest infections, and large meals can trigger heart attacks in vulnerable people, and importantly, how to manage those triggers
-
-
Crucial new funds to help improve heart and kidney disease treatment
Posted on:
Royal North Shore Hospital’s Associate Professor Brendon Neuen will establish an international consortium to support those with both heart and kidney disease. The nephrologist and Director of Kidney Trials will lead the collaboration after being awarded close to $500,000 from NSW Health through a program to drive groundbreaking projects in heart disease. The grant will
-
Kolling Research Symposium 2024
Posted on:
We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop
-
Kolling NEWS
Posted on:
Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There’s a focus too on the first steps towards gene therapy for Meniere’s disease, the latest research into treatments for
-
Innovation at the Kolling’s core
Posted on:
In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare. “Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who
-
Researchers develop urine test based on kidney cell colour and AI to diagnose chronic kidney disease
Posted on:
We may soon have a convenient and painless approach to diagnose chronic kidney disease following research by the team from the Kolling Institute’s Renal Research Laboratory. Chronic kidney disease is an emerging global health issue, currently affecting more than 11 per cent of Australians and 13 per cent of the worldwide population. By 2032, it’s
-
Special Research Feature – Year in Review 2023
Posted on:
Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute. Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders. Our teams have continued to increase their research impact, while forging significant new collaborations. They
Copyright © 2026 Kolling Institute
All rights reserved